BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gu X, Wang L, Boldrup L, Coates PJ, Fahraeus R, Sgaramella N, Wilms T, Nylander K. AP001056.1, A Prognosis-Related Enhancer RNA in Squamous Cell Carcinoma of the Head and Neck. Cancers (Basel) 2019;11:E347. [PMID: 30862109 DOI: 10.3390/cancers11030347] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Sahu D, Lin CC, Goel A. Transcriptomic Profiling Reveals an Enhancer RNA Signature for Recurrence Prediction in Colorectal Cancer. Genes (Basel) 2023;14. [PMID: 36672877 DOI: 10.3390/genes14010137] [Reference Citation Analysis]
2 Chen Y, Jiang N, Chen M, Sui B, Liu X. Identification of tumor antigens and immune subtypes in head and neck squamous cell carcinoma for mRNA vaccine development. Front Cell Dev Biol 2022;10. [DOI: 10.3389/fcell.2022.1064754] [Reference Citation Analysis]
3 Zijian Li, Tao Zeng, Chong Zhou, Yan Chen, Wu Yin. A prognostic signature model for unveiling tumor progression in lung adenocarcinoma. Front Oncol 2022;12:1019442. [PMID: 36387251 DOI: 10.3389/fonc.2022.1019442] [Reference Citation Analysis]
4 Han Y, Shi Y, Chen B, Wang J, Liu Y, Sheng S, Fu Z, Shen C, Wang X, Yin S, Li H. An ion-channel-gene-based prediction model for head and neck squamous cell carcinoma: Prognostic assessment and treatment guidance. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.961695] [Reference Citation Analysis]
5 Gao L, Rong H. Potential mechanisms and prognostic model of eRNAs-regulated genes in stomach adenocarcinoma. Sci Rep 2022;12:16545. [PMID: 36192427 DOI: 10.1038/s41598-022-20824-1] [Reference Citation Analysis]
6 Panahi-Moghadam S, Hassani S, Farivar S, Vakhshiteh F. Emerging Role of Enhancer RNAs as Potential Diagnostic and Prognostic Biomarkers in Cancer. Noncoding RNA 2022;8:66. [PMID: 36287118 DOI: 10.3390/ncrna8050066] [Reference Citation Analysis]
7 Yuan Z, Huang J, Teh BM, Hu S, Hu Y, Shen Y. Exploration of a predictive model based on genes associated with fatty acid metabolism and clinical treatment for head and neck squamous cell carcinoma. J Clin Lab Anal 2022;:e24722. [PMID: 36181275 DOI: 10.1002/jcla.24722] [Reference Citation Analysis]
8 Gan Y, Yang Y, Wu Y, Li T, Liu L, Liang F, Qi J, Liang P, Pan D. Comprehensive transcriptomic analysis of immune-related eRNAs associated with prognosis and immune microenvironment in melanoma. Front Surg 2022;9. [DOI: 10.3389/fsurg.2022.917061] [Reference Citation Analysis]
9 Chen P, Qi D, Sun K, Song S, Li T. Identification of novel enhancer RNA biomarkers and corresponding prognostic signatures of hepatocellular carcinoma.. [DOI: 10.21203/rs.3.rs-1703926/v2] [Reference Citation Analysis]
10 Qin W, He C, Jiang D, Gao Y, Chen Y, Su M, Yang Y, Yang Z, Cai H, Wang H, Wang F. Systematic Construction and Validation of a Novel Ferroptosis-Related Gene Model for Predicting Prognosis in Cervical Cancer. Journal of Immunology Research 2022;2022:1-29. [DOI: 10.1155/2022/2148215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Yang S, Zou X, Yang H, Li J, Zhang A, Zhang L, Li C, Zhu L, Ma Z. Identification of Enhancer RNA CDK6-AS1 as a Potential Novel Prognostic Biomarker in Gastric Cancer. Front Genet 2022;13:854211. [DOI: 10.3389/fgene.2022.854211] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Jiang M, Liu F, Yang AG, Wang W, Zhang R. The role of long non-coding RNAs in the pathogenesis of head and neck squamous cell carcinoma. Mol Ther Oncolytics 2022;24:127-38. [PMID: 35024439 DOI: 10.1016/j.omto.2021.12.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
13 Ye T, Li LL, Peng XM, Li Q. CYP1B1-AS1 Is a Novel Biomarker in Glioblastoma by Comprehensive Analysis. Dis Markers 2021;2021:8565943. [PMID: 35003394 DOI: 10.1155/2021/8565943] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Yan T, Wang K, Zhao Q, Zhuang J, Shen H, Ma G, Cong L, Du J. Gender specific eRNA TBX5-AS1 as the immunological biomarker for male patients with lung squamous cell carcinoma in pan-cancer screening. PeerJ 2021;9:e12536. [PMID: 34900441 DOI: 10.7717/peerj.12536] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Wu H, Zhang J, Bai Y, Zhang S, Zhang Z, Tong W, Han P, Fu B, Zhang Y, Shen Z. DCP1A is an unfavorable prognostic-related enhancer RNA in hepatocellular carcinoma. Aging (Albany NY) 2021;13:23020-35. [PMID: 34609335 DOI: 10.18632/aging.203593] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
16 Feng G, Wang T, Xue F, Qi Y, Wang R, Yuan H. Identification of enhancer RNAs for the prognosis of head and neck squamous cell carcinoma. Head Neck 2021;43:3820-31. [PMID: 34569097 DOI: 10.1002/hed.26877] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Lin H, Yang Y, Hou C, Zheng J, Lv G, Mao R, Xu P, Chen S, Zhou Y, Wang P, Zhou D. An integrated analysis of enhancer RNAs in glioma and a validation of their prognostic values. Am J Transl Res 2021;13:8611-31. [PMID: 34539983] [Reference Citation Analysis]
18 Ang X, Xu Z, Zhou Q, Zhang Z, Ma L, Zhang X, Zhou F, Chen W. PARGP1, a specific enhancer RNA associated with biochemical recurrence of prostate cancer. All Life 2021;14:774-81. [DOI: 10.1080/26895293.2021.1969292] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Deng Y, Li K, Tan F, Liu H. Gene Model Related to m6A Predicts the Prognostic Effect of Immune Infiltration on Head and Neck Squamous Cell Carcinoma. J Oncol 2021;2021:1814266. [PMID: 34457003 DOI: 10.1155/2021/1814266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Tsai JC, Saad OA, Magesh S, Xu J, Lee AC, Li WT, Chakladar J, Fuster MM, Chang EY, Wang-Rodriguez J, Ongkeko WM. Tobacco Smoke and Electronic Cigarette Vapor Alter Enhancer RNA Expression That Can Regulate the Pathogenesis of Lung Squamous Cell Carcinoma. Cancers (Basel) 2021;13:4225. [PMID: 34439379 DOI: 10.3390/cancers13164225] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Ye R, Cao C, Xue Y. Enhancer RNA: biogenesis, function, and regulation. Essays Biochem 2020;64:883-94. [PMID: 33034351 DOI: 10.1042/EBC20200014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
22 Cheng L, Han T, Chen B, Nie K, Peng W. TBX5-AS1, an enhancer RNA, is a potential novel prognostic biomarker for lung adenocarcinoma. BMC Cancer 2021;21:794. [PMID: 34238250 DOI: 10.1186/s12885-021-08517-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
23 Liu B, Su Q, Ma J, Chen C, Wang L, Che F, Heng X. Prognostic Value of Eight-Gene Signature in Head and Neck Squamous Carcinoma. Front Oncol 2021;11:657002. [PMID: 34221975 DOI: 10.3389/fonc.2021.657002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
24 He F, Chen Z, Deng W, Zhan T, Huang X, Zheng Y, Yang H. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma. Int Immunopharmacol 2021;98:107789. [PMID: 34130150 DOI: 10.1016/j.intimp.2021.107789] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
25 Cai S, Hu X, Chen R, Zhang Y. Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma. Front Genet 2021;12:657051. [PMID: 34178028 DOI: 10.3389/fgene.2021.657051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
26 Wang R, Tang Q. Current Advances on the Important Roles of Enhancer RNAs in Molecular Pathways of Cancer. Int J Mol Sci 2021;22:5640. [PMID: 34073237 DOI: 10.3390/ijms22115640] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Hua T, Tian YJ, Wang RM, Zhao CF, Kong YH, Tian RQ, Wang W, Ma LX. FOXP4-AS1 is a favorable prognostic-related enhancer RNA in ovarian cancer. Biosci Rep 2021;41:BSR20204008. [PMID: 33870423 DOI: 10.1042/BSR20204008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
28 Xiao J, Liu Y, Yi J, Liu X. LINC02257, an Enhancer RNA of Prognostic Value in Colon Adenocarcinoma, Correlates With Multi-Omics Immunotherapy-Related Analysis in 33 Cancers. Front Mol Biosci 2021;8:646786. [PMID: 33996902 DOI: 10.3389/fmolb.2021.646786] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
29 Uddin F, Srivastava M. Characterization of transcripts emanating from enhancer Eβ of the murine TCRβ locus. FEBS Open Bio 2021;11:1014-28. [PMID: 33426767 DOI: 10.1002/2211-5463.13079] [Reference Citation Analysis]
30 Odame E, Chen Y, Zheng S, Dai D, Kyei B, Zhan S, Cao J, Guo J, Zhong T, Wang L, Li L, Zhang H. Enhancer RNAs: transcriptional regulators and workmates of NamiRNAs in myogenesis. Cell Mol Biol Lett 2021;26:4. [PMID: 33568070 DOI: 10.1186/s11658-021-00248-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Tao H, Li H, Xu K, Hong H, Jiang S, Du G, Wang J, Sun Y, Huang X, Ding Y, Li F, Zheng X, Chen H, Bo X. Computational methods for the prediction of chromatin interaction and organization using sequence and epigenomic profiles. Brief Bioinform 2021:bbaa405. [PMID: 33454752 DOI: 10.1093/bib/bbaa405] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
32 Jiang H, Chen H, Wan P, Song S, Chen N. Downregulation of enhancer RNA EMX2OS is associated with poor prognosis in kidney renal clear cell carcinoma. Aging (Albany NY) 2020;12:25865-77. [PMID: 33234727 DOI: 10.18632/aging.202151] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
33 Zhang F, Liu Y, Yang Y, Yang K. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma. BMC Cancer 2020;20:1015. [PMID: 33081731 DOI: 10.1186/s12885-020-07489-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
34 Ma T, Ma N, Chen JL, Tang FX, Zong Z, Yu ZM, Chen S, Zhou TC. Expression and prognostic value of Chromobox family members in gastric cancer. J Gastrointest Oncol 2020;11:983-98. [PMID: 33209492 DOI: 10.21037/jgo-20-223] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
35 Lee JH, Xiong F, Li W. Enhancer RNAs in cancer: regulation, mechanisms and therapeutic potential. RNA Biol 2020;17:1550-9. [PMID: 31916476 DOI: 10.1080/15476286.2020.1712895] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 12.0] [Reference Citation Analysis]
36 Arnold PR, Wells AD, Li XC. Diversity and Emerging Roles of Enhancer RNA in Regulation of Gene Expression and Cell Fate. Front Cell Dev Biol 2019;7:377. [PMID: 31993419 DOI: 10.3389/fcell.2019.00377] [Cited by in Crossref: 91] [Cited by in F6Publishing: 94] [Article Influence: 30.3] [Reference Citation Analysis]